EFINACONAZOLE Impurity

Efinaconazole impurity is a structurally related synthetic byproduct arising from incomplete alkylation during triazole ring formation. It retains the core 1H-1,2,4-triazole scaffold and 4-fluorophenyl substituent but features a truncated propyl chain with a terminal hydroxymethyl group instead of the parent drug's secondary alcohol. This positional isomer exhibits distinct HPLC retention due to altered hydrophobicity, serving as a critical reference standard for quantifying process-derived impurities in efinaconazole bulk drug substance analysis.